NCT06180759View on ClinicalTrials.gov

Acute Analgesic Effects of DMT on Experimentally Induced Pain in Healthy Participants

PHASE1RecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 23, 2025

Primary Completion Date

August 30, 2025

Study Completion Date

September 28, 2025

Conditions
Healthy
Interventions
DRUG

Intravenous infusion of DMT

A dose rate of 1.2 mg/min will be administered

DRUG

Intravenous infusion of ketamine

A dose rate of 1.0 mg/min will be administered

DRUG

Intravenous infusion of placebo

A Placebo (saline infusion) will be administered.

Trial Locations (1)

4056

RECRUITING

Clinical Pharmacology & Toxicology, University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER